Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Birmingham Featured PhD Programmes
Imperial College London Featured PhD Programmes
Swansea University Featured PhD Programmes
University of St Andrews Featured PhD Programmes
University of Manchester Featured PhD Programmes
"lung" AND "cancer"×
10 miles

lung cancer PhD Projects, Programs & Scholarships

We have 29 lung cancer PhD Projects, Programs & Scholarships

  • "lung" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 29
  PhD In Population Medicine - Engaging high-risk disadvantaged populations in shared decision making about low-dose computed tomography lung cancer screening
  Dr N Joseph-Williams, Dr KE Brain
Application Deadline: 27 February 2019
Low-dose computed tomography (LDCT) lung cancer screening has become the standard of care for high-risk groups in the US, and the case for implementation of stratified screening is building in the UK.
  Carbonic anhydrases as a molecular target to destroy the therapy resistant cancer stem cells in small cell lung cancer (RDF19/HLS/AS/GIELING)
  Dr R Gieling
Application Deadline: 25 January 2019
Cancer treatment is often compromised by populations of cells which are resistant to the therapy. These cells possess stemness properties and are therefore often regarded to be the cancer stem cells (CSCs).
  Statistical methods for integrating multi-omics sequence data and unveiling molecular underpinnings of non-small cell lung cancer
  Prof Z Luo, Dr L Leach
Applications accepted all year round
The past decade has witnessed tremendous advancements in sequencing technologies, enabling collection of highly accurate and high resolution data on the structure and function of the genome.
  Discovering the protective immune response to lung cancer
  Prof B Chain, Dr S Quezada, Prof C Swanton
Application Deadline: 14 December 2018
The immune system plays a key role in controlling cancer and recent clinical trials have demonstrated that enhancing anti-cancer immunity can result in dramatic improvements in patient outcome and survival.
  Exploiting cyclic dipeptides as improved anticancer therapeutics
  Research Group: Biomedical Sciences Research Centre
  Dr CM Czekster, Prof D Harrison
Application Deadline: 15 February 2019
Background and project details. Lung cancer is the most common cause of cancer deaths in both males and females. In the UK, of the total deaths caused by cancer 21% are caused by lung cancer alone.
  Optimising Repair of the Thoracic Wall Following Thoracic Surgery
  Dr C Bergeles
Applications accepted all year round
First Supervisor. Professor Kawal Rhode. Second Supervisor. Dr Christos Bergeles. Lung cancer is the most common cause of cancer death in the UK.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round
Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  Molecular mechanisms underpinning EML4 driven microtubule stabilization and cell migration
  Dr A M Fry, Prof K Brown
Application Deadline: 1 January 2019
EML4 is a poorly characterised microtubule-associated protein [1]. The purpose of this cell biology-focused PhD project is to explore the molecular mechanisms through which EML4 regulates microtubule dynamics and cell migration.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
  Statistical and Molecular Genetics of Complex Traits
  Prof Z Luo
Applications accepted all year round
Most characters of any living organism are polygenically controlled and environmentally modified, including those threatening human health and those important in breeding for high yield, better quality and improved adaption of animals, plants and microbes.
Show 10 15 30 per page

FindAPhD. Copyright 2005-2018
All rights reserved.